[Direct answer]In the Beijing area, the trial sponsors generally bear the responsibility for compensation or damages, and medical institutions with faults shall be dealt with in accordance with the liability for medical harm. Article 121 of the Civil Code of the People's Republic of China stipulates that if a patient suffers harm during the diagnosis and treatment activities and the medical institution or its medical staff are at fault, the medical institution shall bear the liability for compensation. Article 122 stipulates that when performing surgeries, special examinations, or special treatments, the risks and alternative solutions shall be explained and clear consent shall be obtained. Drug clinical trials are also subject to the Drug Administration Law of the People's Republic of China (amended in 2019).

1. Problem background and typical scenarios

Drug trial subjects often suffer harm during clinical trials of new drugs and bioequivalence studies. Typical scenarios include: subjects experiencing severe adverse reactions or even disabilities after taking the experimental drug; being required to sign consent forms without being fully informed of the risks during the trial; both sponsors and medical institutions shifting blame after adverse events occur; unclear responsibilities for trial-related examinations, treatment costs, and follow-up treatment; and unreasonable obstacles being set for subjects who withdraw from the trial. When handling such disputes in Beijing, authorities typically review whether the trial was approved in accordance with the law, whether it underwent ethical review, whether the informed consent was genuine and sufficient, and the causal relationship between the harm and the experimental drug. It should be noted that such disputes often involve both factual determinations and procedural requirements, with relevant materials often scattered among both parties. Additionally, due to short deadlines and high professional complexity, the earlier evidence is systematically organized, time points and legal basis are clarified, the more options there are for subsequent negotiations or litigation, and the better the chances of avoiding losing favorable positions due to procedural errors. In specific analysis, it is recommended to take the timeline as the main line, and to correspond contractual documents, receipts, communication records, and relevant legal basis one by one, forming a clear processing framework to facilitate the determination of the chronological order and feasibility of various claims.

II. Key points of contention

Firstly, whether there is a causal relationship between the experimental drug or the experimental procedure and the damage. Secondly, whether the informed consent is genuine and sufficient, and whether there is any concealment or inducement. Thirdly, whether the responsible party is the sponsor, the research institution, or whether they should share responsibility. Fourthly, whether the trial has been approved and subject to ethical review, and whether the procedures comply with regulations. Fifthly, how to determine the scope of compensation and indemnification. Sixthly, the impact of the subject's underlying diseases on the consequences of the damage. Seventhly, whether the subject claiming rights is qualified and whether any necessary counterparties and jointly responsible parties have been omitted. Eighthly, whether the integrity of the evidence and the allocation of the burden of proof will directly affect the outcome. Ninthly, how to determine and prove the scope of losses, causal relationships, and the degree of the parties' own faults all require verification on a case-by-case basis with specific materials. In addition, attention should be paid to whether the form of evidence is legal, whether key facts can corroborate each other, and the differences in cost, time, and feasibility of different handling solutions. On this basis, the priority path to be pursued should be determined.

III. Professional analysis by Henglue Law Firm

The practical experience of Henglue Lawyers is that in cases of harm to subjects, it is necessary to first fix the informed consent and adverse event records. Firstly, collect the informed consent form, the summary of the trial protocol, medication records, adverse event reports, and follow-up records to confirm the time of the harm and its relationship with the medication. Secondly, review the authenticity of the informed consent, focusing on whether the nature of the trial, risks, alternative treatments, and compensation arrangements have been fully disclosed, and whether there is any disguised pressure. Thirdly, clarify the responsible parties: the sponsor usually bears the responsibility for compensation or damages related to the trial, and the research institutions shall handle the damages caused by their faults in the medical treatment process in accordance with the liability for medical damages. If necessary, the relevant parties can be listed as responsible parties together. Fourthly, confirm the causality and causative factors between the harm and the trial medication through appraisal. Fifthly, claim for medical expenses, nursing fees, disability compensation, and compensation for mental damage based on the evidence, and advocate for reasonable follow-up treatment guarantees. The lawyers will assist the subjects in clarifying the scope of compensation and damages they can claim in accordance with regulatory requirements.

IV. Practical suggestions and legal basis

Action list: First, preserve the informed consent form and materials related to the trial; Second, seek medical treatment promptly and keep the diagnosis and treatment records; Third, fix the adverse event reports and follow-up records to prove the correlation; Fourth, clarify the responsibilities of the sponsor and the research institution; Fifth, apply for an appraisal to confirm the causality when necessary; Sixth, pay attention to the statute of limitations and consult professional lawyers in a timely manner. For medical disputes and personal injuries, you can refer to the relevant provisions.Personal injury and medical disputesFor contracts and compensation agreements related to the experiment, you can refer to the following for reference.Business and contract disputes in enterprisesLegal basis: Articles 1228 and 1229 of the Civil Code of the People's Republic of China (both effective since January 1, 2021), the Pharmaceutical Administration Law of the People's Republic of China (amended in 2019 and effective since December 1, 2019), and the Quality Management Guidelines for Clinical Trials of Drugs (effective since July 1, 2020). The specific application shall be subject to the currently effective laws, regulations, and judicial rulings.

5. Henglue Law Firm's Reminder

Firstly, the informed consent form and the trial records are the core evidence for protecting rights. Secondly, it is necessary to distinguish the sponsor's compensation liability from the research institution's liability for medical treatment errors. Thirdly, the causality is usually determined by the appraisal conclusion. Fourthly, the subject's underlying diseases will affect the causality and the proportion of liability. Fifthly, it is essential to fully understand the risks and compensation arrangements before signing the consent form. For cases involving drug trial damages and medical claims, it can be resolved through legal channels.Personal injury and medical disputesThe service receives support, and the trial contracts and compensation agreements involved can be combined together.Business and contract disputes in enterprisesFor plates involving the enforcement of compensation payments, you can refer to the following for referenceCreditor's rights and debts, and enforcementColumn.

VI. Frequently Asked Questions

Q1: Who should compensate for the injuries suffered during participation in drug trials?

Generally, the trial sponsor shall bear the liability for compensation or indemnity for any relevant damages suffered by the subjects due to the trial, and shall safeguard the subjects' rights and interests through insurance and other means; if the medical institution is at fault in the process of diagnosis and treatment, it may claim compensation separately according to the liability for medical damage. The specific responsible parties and scope need to be determined in combination with the trial plan and evidence. There are significant differences in the form of evidence, liability ratio, and procedural nodes among individual cases. Such claims are usually subject to statutory time limits. It is recommended to fix written evidence as soon as possible, claim rights in a timely manner, and keep records of reminders, communications, and service delivery to avoid the results being affected by insufficient evidence or the expiration of time limits. The specific plan should be determined by a professional lawyer after evaluating the complete materials.

Q2: Can I still claim compensation if I've signed the informed consent form?

Yes. The informed consent form is a proof of the subject's voluntary participation, but it does not automatically exempt the sponsor or medical institution from their legal obligations of compensation and liability. If there are circumstances such as insufficient disclosure of risks, concealment of important information, or a causal relationship between the experimental drug and the harm, the subject can still claim rights according to law. The specific cases vary greatly in terms of evidence form, liability proportion, and procedural timelines, and relevant claims are usually subject to statutory time limits. It is recommended to fix written evidence as soon as possible, claim rights in a timely manner, and keep records of reminders, communication, and service delivery to avoid the results being affected by insufficient evidence or expired time limits. The specific plan should be determined by a professional lawyer after evaluating the complete materials.

Q3: How to prove that the damage is related to the experimental drug?

The causality and causative factors can be confirmed through the timeline of medication and adverse events, adverse event reports, laboratory tests, and follow-up records, among other materials. When necessary, an appraisal can be applied to confirm the causality and causative factors. Timely and complete preservation of trial-related records is crucial to avoid difficulties in providing evidence due to missing information. Cases vary greatly in terms of evidence forms, liability ratios, and procedural milestones, and related requests are usually subject to statutory time limits. It is recommended to fix written evidence as soon as possible, assert rights in a timely manner, and retain records of reminders, communications, and service delivery to avoid the outcome being affected by insufficient evidence or the expiration of time limits. Specific solutions should be determined after a professional lawyer evaluates the complete materials.

Q4: What kinds of compensation or damages can be claimed?

Generally, the claimant may seek compensation for medical expenses, nursing care fees, loss of income, and transportation costs arising from the damage. For cases involving disability, compensation for disability is included; for cases involving death, compensation for death and funeral expenses are included. The claimant may also seek compensation for mental distress and reasonable follow-up treatment guarantees, which shall be determined based on the evidence and appraisal conclusions. Cases vary greatly in terms of evidence form, liability ratio, and procedural timelines. Relevant claims are typically subject to statutory time limits. It is recommended to secure written evidence as soon as possible, assert rights promptly, and keep records of reminders, communications, and service notifications to avoid outcomes being affected by insufficient evidence or expired time limits. Specific solutions should be determined by professional lawyers after evaluating the complete materials.

Q5: Is it possible to withdraw from the experiment midway?

Yes. Subjects have the right to withdraw from clinical trials at any time without being discriminated against or having their medical treatment affected. If unreasonable obstacles are set up or benefits are withheld due to withdrawal, they can report the matter to the ethics committee or the competent authority and keep relevant communication records as evidence. Cases vary greatly in terms of evidence form, liability proportion, and procedural nodes. Relevant requests are usually subject to statutory time limits. It is recommended to fix written evidence as soon as possible, assert rights in a timely manner, and keep records of reminders, communications, and deliveries to avoid the outcome being affected by insufficient evidence or the expiration of deadlines. Specific solutions should be determined by professional lawyers after evaluating the complete materials.

The above Q&A is mainly based on the judicial practice in Beijing. There may be differences in the adjudication standards in different regions. It is recommended to consult a professional lawyer based on the specific circumstances of the case.

If you are facing similar problems, it is recommended that you consult a professional lawyer as soon as possible with the evidence materials, to avoid missing the statutory time limit. →Personal injury legal services·Beijing Henglu Law Firm

Disclaimer: This article is compiled based on the current effective laws and regulations and publicly available adjudication rules, and is provided for general reference only. It does not constitute a formal legal opinion on specific cases. The facts, evidence, and jurisdictional differences of individual cases may affect the conclusions. In the event of a dispute, please consult a practicing lawyer in a timely manner.